Coherus Oncology
CHRS
CHRS
174 hedge funds and large institutions have $744M invested in Coherus Oncology in 2022 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 69 increasing their positions, 59 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
2.37% less ownership
Funds ownership: 101.92% → 99.55% (-2.4%)
99% less call options, than puts
Call options by funds: $4K | Put options by funds: $679K
Holders
174
Holding in Top 10
–
Calls
$4K
Puts
$679K
Top Buyers
| 1 | +$8.51M | |
| 2 | +$4.15M | |
| 3 | +$3.38M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.32M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$2.81M |
Top Sellers
| 1 | -$19M | |
| 2 | -$12.3M | |
| 3 | -$3.47M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$3.04M |
| 5 |
Nordea Investment Management
Stockholm,
Sweden
|
-$2.77M |